Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.

Autor: Kerekes G; Intensive Care Unit, Department of Medicine, University of Debrecen, Debrecen, Hungary., Czókolyová M; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Hamar A; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pusztai A; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Tajti G; Department of Biophysics and Cell Biology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Katkó M; Division of Metabolic Diseases, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Végh E; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pethő Z; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Bodnár N; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Horváth Á; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Soós B; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szamosi S; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Hascsi Z; ScanoMed Ltd, Debrecen, Hungary., Harangi M; Division of Metabolic Diseases, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Hodosi K; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Panyi G; Department of Biophysics and Cell Biology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Seres T; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Szűcs G; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szekanecz Z; Department of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Oct 23; Vol. 62 (SI3), pp. SI304-SI312.

Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach.

Autor: Soós B; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Hamar A; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pusztai A; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Czókolyová M; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Végh E; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szamosi S; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pethő Z; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Gulyás K; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Kerekes G; Intensive Care Unit, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szántó S; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Department of Sports Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szűcs G; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Christians U; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States., Klawitter J; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States., Seres T; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States., Szekanecz Z; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2022 Nov 10; Vol. 9, pp. 1011734. Date of Electronic Publication: 2022 Nov 10 (Print Publication: 2022).

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Autor: Soós B; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Fagyas M; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Horváth Á; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Végh E; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pusztai A; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Czókolyová M; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Csongrádi A; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Hamar A; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pethő Z; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Bodnár N; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Kerekes G; Intensive Care Unit, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Hodosi K; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szekanecz É; Department of Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szamosi S; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szántó S; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Department of Sports Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szűcs G; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Papp Z; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szekanecz Z; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2022 Jan 27; Vol. 8, pp. 785744. Date of Electronic Publication: 2022 Jan 27 (Print Publication: 2021).

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Autor: Czókolyová M; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Pusztai A; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Végh E; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Horváth Á; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Szentpéteri A; Division of Metabolic Diseases, Department of Medicine, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Hamar A; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Szamosi S; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Hodosi K; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Domján A; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Szántó S; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary.; Department of Sports Medicine, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Kerekes G; Intensive Care Unit, Department of Medicine, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Seres I; Division of Metabolic Diseases, Department of Medicine, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Harangi M; Division of Metabolic Diseases, Department of Medicine, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Paragh G; Division of Metabolic Diseases, Department of Medicine, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Szekanecz É; Department of Oncology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Szekanecz Z; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary., Szűcs G; Division of Rheumatology, Faculty of Medicine, University of Debrecen, 4031 Debrecen, Hungary.

Publikováno v: Biomolecules [Biomolecules] 2021 Oct 18; Vol. 11 (10). Date of Electronic Publication: 2021 Oct 18.

Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.

Autor: Pusztai A; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Hamar A; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Horváth Á; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Gulyás K; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Végh E; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Bodnár N; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Kerekes G; G. Kerekes, MD, PhD, Intensive Care Unit, Department of Medicine, University of Debrecen, Debrecen, Hungary., Czókolyová M; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Szamosi S; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Bodoki L; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Hodosi K; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Domján A; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Nagy G; G. Nagy, MD, PhD, I. Szöllősi, Department of Laboratory Medicine, University of Debrecen, Debrecen, Hungary., Szöllősi I; G. Nagy, MD, PhD, I. Szöllősi, Department of Laboratory Medicine, University of Debrecen, Debrecen, Hungary., Lopez LR; L.R. Lopez, MD, PhD, Corgenix Inc., Broomfield, Colorado, USA., Matsuura E; E. Matsuura, MD, PhD, Okayama University Graduate School of Medicine, Okayama, Japan., Prohászka Z; Z. Prohászka, MD, PhD, Third Department of Internal Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Szántó S; S. Szántó, MD, PhD, Division of Rheumatology, Department of Medicine, and Department of Sports Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Nagy Z; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary., Shoenfeld Y; Y. Shoenfeld, MD, PhD, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel., Szekanecz Z; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary; szekanecz.zoltan@med.unideb.hu., Szűcs G; A. Pusztai, A. Hamar, MD, Á. Horváth, MD, K. Gulyás, MD, E. Végh, MD, N. Bodnár, MD, PhD, M. Czókolyová, S. Szamosi, MD, PhD, L. Bodoki, MD, PhD, K. Hodosi, A. Domján, Z. Nagy, MD, PhD, Z. Szekanecz, MD, PhD, G. Szűcs, MD, PhD, Division of Rheumatology, Department of Medicine, University of Debrecen, Debrecen, Hungary.

Publikováno v: The Journal of rheumatology [J Rheumatol] 2021 Jun; Vol. 48 (6), pp. 821-828. Date of Electronic Publication: 2020 Dec 15.